Artelo Biosciences, Inc. announced that it will receive $20,096,972 in funding on May 13, 2022. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +4.41% | +5.97% | +1.43% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.43% | 4.39M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced a financing transaction